Engagements

Mandates measured in risk reduced, cost saved and revenue earned.

A selection of executive transformation engagements, anonymised where confidentiality requires. Each was board-sponsored and delivered under direct senior partner accountability.

Financial Systems

Re-anchoring a Tier-1 bank's GenAI program around measurable P&L.

Discuss a comparable mandate →

Situation

47 disconnected GenAI pilots across 11 business units. €38M committed, no executive owner, mounting regulator attention.

Risk

Uninsurable model exposure, capital-treatment ambiguity, and ExCo credibility loss if the next supervisory review landed first.

Intervention

Charter Method L·01–L·04: board mandate reset, value-pool diagnostic, federated governance design, partner-led ExCo cadence.

Outcome

Consolidated to 6 prioritised programs with named value owners. €112M annualised run-rate impact in 14 months. ExCo governance live.

Partner insight

"GenAI sprawl is rarely a tooling problem. It is a mandate problem the CFO is best placed to solve."

−71%

Pilot sprawl

€112M

Annualised value

18→6

Strategic bets

Public & Sovereign Systems

Sovereign AI strategy and AI office stand-up for a G20 ministry.

Discuss a comparable mandate →

Situation

No national AI mandate, fragmented agency procurement, growing public-trust deficit on data and automation.

Risk

Doctrine vacuum — sovereignty defined by whichever foreign vendor signed the next ministry first.

Intervention

Cabinet-grade strategy authored under partner accountability; AI Office structure, statutes and sovereign compute partnership designed in parallel.

Outcome

Cabinet-approved national AI strategy, operational AI Office, sovereign compute partnership signed — 9 months from kick-off.

Partner insight

"Sovereign AI is not a stack to procure. It is a doctrine to write, with institutions accountable for it."

9 mo

Strategy to operations

Statutes drafted

1st

National AI Office in region

Human Systems

Clinical AI assurance program for a national health system.

Discuss a comparable mandate →

Situation

57 AI/ML clinical models in production with no central inventory. Regulator pressure escalating, board-level liability exposed.

Risk

A single adverse clinical event involving an ungoverned model would trigger statutory inquiry and indemnity collapse.

Intervention

Full model inventory, risk-tiered governance, EU AI Act high-risk classification, continuous assurance pipeline — partner-led.

Outcome

100% high-risk coverage. Zero regulatory findings on follow-up. Board liability quantified and capped.

Partner insight

"Clinical AI does not fail at the model. It fails at the inventory the board did not know existed."

Models under governance

100%

High-risk coverage

Regulatory findings on follow-up

Industrial & Digital Economy

AI operating model redesign for a pan-African telecom group.

Discuss a comparable mandate →

Situation

Local AI teams in 14 markets. Duplicated tooling, fragmented vendors, run-cost spiralling with no group-level visibility.

Risk

Group AI spend on track to exceed CAPEX envelope by FY+2 with no measurable revenue contribution.

Intervention

Federated AI Centre of Excellence designed and stood up; shared MLOps platform; group governance and FinOps overlay.

Outcome

38% reduction in group AI run-cost. 14 markets on one platform. 3× deployment velocity within 11 months.

Partner insight

"The AI operating model — not the model itself — decides whether multi-market scale compounds or cannibalises."

−38%

Group AI run-cost

Markets on one platform

3×

Time-to-deploy

Engage

Your transformation, on the record.

Bring us a mandate worth a case study. We bring the partners, the framework and accountability for outcomes.

Request Advisory Engagement →Speak to an Advisory Partner